Role of Olaparib as Maintenance Treatment for Ovarian Cancer: The Evidence to Date

被引：24

作者：

Montemorano, Lauren ^{[1
]}

Lightfoot, Michelle D. S. ^{[2
]}

Bixel, Kristin ^{[2
]}

机构：

[1] Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA

[2] Ohio State Univ, Wexner Med Ctr, James Canc Hosp, Dept Obstet & Gynecol,Div Gynecol Oncol, Columbus, OH 43210 USA

来源：

ONCOTARGETS AND THERAPY | 2019年 / 12卷

关键词：

olaparib; PARP inhibitor; ovarian cancer; maintenance; DOUBLE-BLIND; THERAPY; CHEMOTHERAPY; BEVACIZUMAB; INHIBITORS; CARCINOMA;

D O I：

10.2147/OTT.S195552

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

PARP inhibitors have shown significant promise in the treatment of ovarian cancer. Olaparib is a PARP inhibitor that has been approved for maintenance for BRCA-mutated ovarian cancer in the recurrent and front-line setting as well as for treatment of BRCA-mutated ovarian cancer in patients who have received multiple prior lines of chemotherapy. In this review, we focus on the use of olaparib in the maintenance setting including the evidence to date, ongoing research, and future directions.

引用

页码：11497 / 11506

页数：10

共 50 条

[1] Olaparib as maintenance therapy for ovarian cancer
Nature Reviews Clinical Oncology, 2012, 9 (6) : 306 - 306
[2] Maintenance olaparib in advanced ovarian cancer
Burki, Talha Khan
LANCET ONCOLOGY, 2018, 19 (12): : E671 - E671
[3] Olaparib for the treatment of ovarian cancer
Lheureux, Stephanie
Oza, Amit M.
EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 497 - 508
[4] Olaparib in the treatment of ovarian cancer
Washington, Christina R.
Richardson, Debra L.
Moore, Kathleen N.
FUTURE ONCOLOGY, 2019, 15 (30) : 3435 - 3449
[5] OLAPARIB FOR THE TREATMENT OF OVARIAN CANCER
Bornstein, E.
Jimeno, A.
DRUGS OF TODAY, 2016, 52 (01) : 17 - 28
[6] Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
Ledermann, Jonathan A.
Pujade-Lauraine, Eric
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
[7] Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy
Heo, Young-A
Dhillon, Sohita
TARGETED ONCOLOGY, 2018, 13 (06) : 801 - 808
[8] Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy
Young-A Heo
Sohita Dhillon
Targeted Oncology, 2018, 13 : 801 - 808
[9] OVARIAN CANCER Olaparib maintenance moves to first line
Sidaway, Peter
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) : 725 - 725
[10] Olaparib for the treatment of epithelial ovarian cancer
McLachlan, Jennifer
Banerjee, Susana
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 995 - 1003

← 1 2 3 4 5 →